Selected research
Industry Growth & Trends
Global Exosome Isolation Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Exosome Isolation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Exosome Isolation Service market include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Creative Biostructure, AMSBIO, Everzom, System Biosciences and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Exosome Isolation Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Exosome Isolation Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exosome Isolation Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exosome Isolation Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Exosome Isolation Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Exosome Isolation Service Market by Company
Codiak Biosciences
Aethlon Medical
NanoSomix
Aruna Bio
Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Biolabs
Frontage Labs
Lonza
Capital Biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible
Exosome Isolation Service Segment by Type
Ultracentrifugation
Immunomagnetic Bead Method
Size Exclusion Chromatography
Exosome Isolation Service Segment by Application
Early Cancer Screening
Neurological Disease Diagnosis
Drug Delivery System Development
Regenerative Medicine
Other
Exosome Isolation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Exosome Isolation Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Ultracentrifugation
- Immunomagnetic Bead Method
- Size Exclusion Chromatography
Applications
- Early Cancer Screening
- Neurological Disease Diagnosis
- Drug Delivery System Development
- Regenerative Medicine
- Other
Companies covered
- Codiak Biosciences
- Aethlon Medical
- NanoSomix
- Aruna Bio
- Creative Biostructure
- AMSBIO
- Everzom
- System Biosciences
- Creative Biolabs
- Frontage Labs
- Lonza
- Capital Biosciences
- Miltenyi Biotec
- Novus Biologicals
- Clara Biotech
- Immunostep
- ExosomeDx
- Irvine Scientific
- Beckman Coulter
- Stratech
- QIAGEN
- Lifeasible
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Exosome Isolation Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Exosome Isolation Service Market Size by Region (2021-2032)
- 1.4.1 Global Exosome Isolation Service Market Size by Region (2021-2026)
- 1.4.2 Global Exosome Isolation Service Market Size by Region (2027-2032)
- 1.5 Key Regions Exosome Isolation Service Market Size (2021-2032)
- 1.5.1 North America Exosome Isolation Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Exosome Isolation Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Exosome Isolation Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Exosome Isolation Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Exosome Isolation Service Market Size Growth Rate (2021-2032)
2 Exosome Isolation Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Ultracentrifugation
- 2.1.2 Immunomagnetic Bead Method
- 2.1.3 Size Exclusion Chromatography
- 2.2 Global Exosome Isolation Service Market Size by Type
- 2.2.1 Global Exosome Isolation Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Exosome Isolation Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Exosome Isolation Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Exosome Isolation Service Market Size by Regions
- 2.3.1 North America Exosome Isolation Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Exosome Isolation Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Exosome Isolation Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Exosome Isolation Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Exosome Isolation Service Market Size Breakdown by Type (2021-2026)
3 Exosome Isolation Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Early Cancer Screening
- 3.1.2 Neurological Disease Diagnosis
- 3.1.3 Drug Delivery System Development
- 3.1.4 Regenerative Medicine
- 3.1.5 Other
- 3.2 Global Exosome Isolation Service Market Size by Application
- 3.2.1 Global Exosome Isolation Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Exosome Isolation Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Exosome Isolation Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Exosome Isolation Service Market Size by Regions
- 3.3.1 North America Exosome Isolation Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Exosome Isolation Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Exosome Isolation Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Exosome Isolation Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Exosome Isolation Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Exosome Isolation Service Industry Trends
- 4.2 Exosome Isolation Service Industry Drivers
- 4.3 Exosome Isolation Service Industry Opportunities and Challenges
- 4.4 Exosome Isolation Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Exosome Isolation Service Revenue (2021-2026)
- 5.2 Global Exosome Isolation Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Exosome Isolation Service Key Company Headquarters & Area Served
- 5.4 Global Exosome Isolation Service Company, Product Type & Application
- 5.5 Global Exosome Isolation Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Exosome Isolation Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Exosome Isolation Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Exosome Isolation Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Codiak Biosciences
- 6.1.1 Codiak Biosciences Company Information
- 6.1.2 Codiak Biosciences Business Overview
- 6.1.3 Codiak Biosciences Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Codiak Biosciences Exosome Isolation Service Product Portfolio
- 6.1.5 Codiak Biosciences Recent Developments
- 6.2 Aethlon Medical
- 6.2.1 Aethlon Medical Company Information
- 6.2.2 Aethlon Medical Business Overview
- 6.2.3 Aethlon Medical Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aethlon Medical Exosome Isolation Service Product Portfolio
- 6.2.5 Aethlon Medical Recent Developments
- 6.3 NanoSomix
- 6.3.1 NanoSomix Company Information
- 6.3.2 NanoSomix Business Overview
- 6.3.3 NanoSomix Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 NanoSomix Exosome Isolation Service Product Portfolio
- 6.3.5 NanoSomix Recent Developments
- 6.4 Aruna Bio
- 6.4.1 Aruna Bio Company Information
- 6.4.2 Aruna Bio Business Overview
- 6.4.3 Aruna Bio Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Aruna Bio Exosome Isolation Service Product Portfolio
- 6.4.5 Aruna Bio Recent Developments
- 6.5 Creative Biostructure
- 6.5.1 Creative Biostructure Company Information
- 6.5.2 Creative Biostructure Business Overview
- 6.5.3 Creative Biostructure Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Creative Biostructure Exosome Isolation Service Product Portfolio
- 6.5.5 Creative Biostructure Recent Developments
- 6.6 AMSBIO
- 6.6.1 AMSBIO Company Information
- 6.6.2 AMSBIO Business Overview
- 6.6.3 AMSBIO Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 AMSBIO Exosome Isolation Service Product Portfolio
- 6.6.5 AMSBIO Recent Developments
- 6.7 Everzom
- 6.7.1 Everzom Company Information
- 6.7.2 Everzom Business Overview
- 6.7.3 Everzom Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Everzom Exosome Isolation Service Product Portfolio
- 6.7.5 Everzom Recent Developments
- 6.8 System Biosciences
- 6.8.1 System Biosciences Company Information
- 6.8.2 System Biosciences Business Overview
- 6.8.3 System Biosciences Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 System Biosciences Exosome Isolation Service Product Portfolio
- 6.8.5 System Biosciences Recent Developments
- 6.9 Creative Biolabs
- 6.9.1 Creative Biolabs Company Information
- 6.9.2 Creative Biolabs Business Overview
- 6.9.3 Creative Biolabs Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Creative Biolabs Exosome Isolation Service Product Portfolio
- 6.9.5 Creative Biolabs Recent Developments
- 6.10 Frontage Labs
- 6.10.1 Frontage Labs Company Information
- 6.10.2 Frontage Labs Business Overview
- 6.10.3 Frontage Labs Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Frontage Labs Exosome Isolation Service Product Portfolio
- 6.10.5 Frontage Labs Recent Developments
- 6.11 Lonza
- 6.11.1 Lonza Company Information
- 6.11.2 Lonza Business Overview
- 6.11.3 Lonza Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Lonza Exosome Isolation Service Product Portfolio
- 6.11.5 Lonza Recent Developments
- 6.12 Capital Biosciences
- 6.12.1 Capital Biosciences Company Information
- 6.12.2 Capital Biosciences Business Overview
- 6.12.3 Capital Biosciences Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Capital Biosciences Exosome Isolation Service Product Portfolio
- 6.12.5 Capital Biosciences Recent Developments
- 6.13 Miltenyi Biotec
- 6.13.1 Miltenyi Biotec Company Information
- 6.13.2 Miltenyi Biotec Business Overview
- 6.13.3 Miltenyi Biotec Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Miltenyi Biotec Exosome Isolation Service Product Portfolio
- 6.13.5 Miltenyi Biotec Recent Developments
- 6.14 Novus Biologicals
- 6.14.1 Novus Biologicals Company Information
- 6.14.2 Novus Biologicals Business Overview
- 6.14.3 Novus Biologicals Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Novus Biologicals Exosome Isolation Service Product Portfolio
- 6.14.5 Novus Biologicals Recent Developments
- 6.15 Clara Biotech
- 6.15.1 Clara Biotech Company Information
- 6.15.2 Clara Biotech Business Overview
- 6.15.3 Clara Biotech Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Clara Biotech Exosome Isolation Service Product Portfolio
- 6.15.5 Clara Biotech Recent Developments
- 6.16 Immunostep
- 6.16.1 Immunostep Company Information
- 6.16.2 Immunostep Business Overview
- 6.16.3 Immunostep Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Immunostep Exosome Isolation Service Product Portfolio
- 6.16.5 Immunostep Recent Developments
- 6.17 ExosomeDx
- 6.17.1 ExosomeDx Company Information
- 6.17.2 ExosomeDx Business Overview
- 6.17.3 ExosomeDx Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 ExosomeDx Exosome Isolation Service Product Portfolio
- 6.17.5 ExosomeDx Recent Developments
- 6.18 Irvine Scientific
- 6.18.1 Irvine Scientific Company Information
- 6.18.2 Irvine Scientific Business Overview
- 6.18.3 Irvine Scientific Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Irvine Scientific Exosome Isolation Service Product Portfolio
- 6.18.5 Irvine Scientific Recent Developments
- 6.19 Beckman Coulter
- 6.19.1 Beckman Coulter Company Information
- 6.19.2 Beckman Coulter Business Overview
- 6.19.3 Beckman Coulter Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Beckman Coulter Exosome Isolation Service Product Portfolio
- 6.19.5 Beckman Coulter Recent Developments
- 6.20 Stratech
- 6.20.1 Stratech Company Information
- 6.20.2 Stratech Business Overview
- 6.20.3 Stratech Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Stratech Exosome Isolation Service Product Portfolio
- 6.20.5 Stratech Recent Developments
- 6.21 QIAGEN
- 6.21.1 QIAGEN Company Information
- 6.21.2 QIAGEN Business Overview
- 6.21.3 QIAGEN Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 QIAGEN Exosome Isolation Service Product Portfolio
- 6.21.5 QIAGEN Recent Developments
- 6.22 Lifeasible
- 6.22.1 Lifeasible Company Information
- 6.22.2 Lifeasible Business Overview
- 6.22.3 Lifeasible Exosome Isolation Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Lifeasible Exosome Isolation Service Product Portfolio
- 6.22.5 Lifeasible Recent Developments
7 North America
- 7.1 North America Exosome Isolation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Exosome Isolation Service Market Size by Country (2021-2026)
- 7.3 North America Exosome Isolation Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Exosome Isolation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Exosome Isolation Service Market Size by Country (2021-2026)
- 8.3 Europe Exosome Isolation Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Isolation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Exosome Isolation Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Exosome Isolation Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Exosome Isolation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Exosome Isolation Service Market Size by Country (2021-2026)
- 10.3 South America Exosome Isolation Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Isolation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Exosome Isolation Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Exosome Isolation Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst